Angiotensin's enhancement of sympathetic nervous system activity may be a major mechanism underlying the neurogenic component of chronic renal hypertension.
No takes yet. Share an insight, caveat, or question.
Angiotensin-sympathoexcitation may underlie neurogenic renal hypertension; leaves open relevance to current RAAS inhibitor strategies.
McCubbin et al. (1963) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: